NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 45 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $116,000 | -31.0% | 33,461 | 0.0% | 0.00% | – |
Q1 2018 | $168,000 | -92.0% | 33,461 | -90.4% | 0.00% | -100.0% |
Q4 2017 | $2,093,000 | -27.0% | 350,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $2,867,000 | -27.1% | 350,000 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $3,931,000 | – | 350,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |